Last checked at 
(Alliance News) - GlaxoSmithKline PLC and Sanofi SA are close to an agreement to supply the UK government with the Covid-19 vaccine that the two pharmaceutical giants are developing, the Sunday Times reported.
The deal to supply 60 million doses of coronavirus vaccine would be worth GBP500 million, the newspaper said.
The UK business department as taken an option to buy the as-yet unproven vaccine should it work in human trials due to begin in September, according to the Times.
The agreement with the UK and French companies is part of a scramble to secure vaccine supplies, as the US bought most of the world's supply of remdesivir, an antiviral drug made by Foster City, California-based Gilead Sciences Inc, the Times noted.
https://www.thetimes.co.uk/article/glaxo-smith-kline-nears-500m-uk-coronavirus-vaccine-deal-km8xqm3s8
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
